Efficacy of Microecopharmaceutics Combined with Early Enteral Nutrition Support in the Treatment of Severe Acute Pancreatitis

To explore the efficacy of microecopharmaceutics combined with early enteral nutrition support to the treatment of severe acute pancreatitis (SAP). A total of 26 patients diagnosed with SAP in our hospital were retrospectively reviewed. Microecopharmaceutics, the living microbial food supplements that are beneficial to the host by improving the balance of intestinal microorganisms, were combined with early enteral nutrition group, and used as the treatment group; and delayed enteral nutrition was used as the control group. Two weeks after both treatments, variables of C-reactive protein (CRP), albumin (Alb), total serum protein (TP), urinary amylase recovery time, hemodiastase recovery time, acute physiology and chronic health evaluation (APCHE) score, and hospitalisation time in both groups were compared. Alb and TP of the treatment group were significantly higher than those in the control group (p <0.05). The APCHE score and CRP in the treatment group were significantly lower than those in the control group (p <0.05). The urinary amylase recovery time, hemodiastase amylase recovery time, and hospitalisation time in the treatment group were significantly shorter than those in the control group. The use of microecopharmaceutics combined with early enteral nutrition can effectively protect the intestinal barrier function, which is an effective treatment in patients with SAP.